WO2002062984A1 - Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications - Google Patents
Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications Download PDFInfo
- Publication number
- WO2002062984A1 WO2002062984A1 PCT/CN2001/000117 CN0100117W WO02062984A1 WO 2002062984 A1 WO2002062984 A1 WO 2002062984A1 CN 0100117 W CN0100117 W CN 0100117W WO 02062984 A1 WO02062984 A1 WO 02062984A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- yeast
- biological preparations
- specific
- immonological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2001/000117 WO2002062984A1 (fr) | 2001-02-08 | 2001-02-08 | Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2001/000117 WO2002062984A1 (fr) | 2001-02-08 | 2001-02-08 | Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002062984A1 true WO2002062984A1 (fr) | 2002-08-15 |
Family
ID=4574771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2001/000117 WO2002062984A1 (fr) | 2001-02-08 | 2001-02-08 | Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2002062984A1 (fr) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1375652A3 (fr) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Composition orale pour des sujets infectés par le VIH |
EP1375651A3 (fr) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Composition orale pour l'activation et la prolifération des globules blancs |
US6984508B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of cervical cancer |
US6984507B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of lung cancer |
US6987012B2 (en) | 2003-06-11 | 2006-01-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of colorectal cancer |
US6989253B2 (en) | 2003-06-11 | 2006-01-24 | Ultra Biotech Limited | Biological compositions and methods for treatment of testicular cancer |
US7201906B2 (en) | 2003-06-11 | 2007-04-10 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204987B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of prostate cancer |
US7204988B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204986B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7208158B2 (en) | 2003-06-11 | 2007-04-24 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7214377B2 (en) | 2003-06-11 | 2007-05-08 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7220416B2 (en) | 2003-06-11 | 2007-05-22 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223404B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223402B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223403B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223401B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223400B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223405B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepareompositions comprising yeast treated with electromagnetic energy |
US7226600B2 (en) | 2003-06-11 | 2007-06-05 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
WO2011023769A1 (fr) * | 2009-08-26 | 2011-03-03 | Mb Milmed Ab | Composition destinée au traitement de maladies ou de troubles neurodégénératifs, méthode et utilisation impliquant de la levure électromagnétiquement irradiée |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU902462A1 (ru) * | 1980-03-26 | 1982-08-15 | Отдел Биологии Дагестанского Филиала Ан Ссср | Способ выращивани дрожжей |
SU1514777A1 (ru) * | 1987-06-30 | 1989-10-15 | Inst Molekulyarnoj Biolog An S | Способ получения биомассы дрожжей 5асснакомусе5 секеу151аб |
CN1185484A (zh) * | 1996-12-11 | 1998-06-24 | 阿尔瓦罗·V·皮卡卢加 | 调节细胞行为的方法 |
-
2001
- 2001-02-08 WO PCT/CN2001/000117 patent/WO2002062984A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU902462A1 (ru) * | 1980-03-26 | 1982-08-15 | Отдел Биологии Дагестанского Филиала Ан Ссср | Способ выращивани дрожжей |
SU1514777A1 (ru) * | 1987-06-30 | 1989-10-15 | Inst Molekulyarnoj Biolog An S | Способ получения биомассы дрожжей 5асснакомусе5 секеу151аб |
CN1185484A (zh) * | 1996-12-11 | 1998-06-24 | 阿尔瓦罗·V·皮卡卢加 | 调节细胞行为的方法 |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1375652A3 (fr) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Composition orale pour des sujets infectés par le VIH |
EP1375651A3 (fr) * | 2002-06-28 | 2004-01-07 | Ultra Biotech Limited | Composition orale pour l'activation et la prolifération des globules blancs |
US6984508B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of cervical cancer |
US6984507B2 (en) | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of lung cancer |
US6987012B2 (en) | 2003-06-11 | 2006-01-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of colorectal cancer |
US6989253B2 (en) | 2003-06-11 | 2006-01-24 | Ultra Biotech Limited | Biological compositions and methods for treatment of testicular cancer |
US7201906B2 (en) | 2003-06-11 | 2007-04-10 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204987B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Biological compositions and methods for treatment of prostate cancer |
US7204988B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7204986B2 (en) | 2003-06-11 | 2007-04-17 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7208158B2 (en) | 2003-06-11 | 2007-04-24 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7214377B2 (en) | 2003-06-11 | 2007-05-08 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7220416B2 (en) | 2003-06-11 | 2007-05-22 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223404B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223402B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223403B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223401B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223400B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
US7223405B2 (en) | 2003-06-11 | 2007-05-29 | Ultra Biotech Limited | Method to prepareompositions comprising yeast treated with electromagnetic energy |
US7226600B2 (en) | 2003-06-11 | 2007-06-05 | Ultra Biotech Limited | Method to prepare compositions comprising yeast treated with electromagnetic energy |
WO2011023769A1 (fr) * | 2009-08-26 | 2011-03-03 | Mb Milmed Ab | Composition destinée au traitement de maladies ou de troubles neurodégénératifs, méthode et utilisation impliquant de la levure électromagnétiquement irradiée |
CN102481368A (zh) * | 2009-08-26 | 2012-05-30 | 密美德有限公司 | 包含电磁辐射的酵母的治疗神经变性疾病或病症的组合物、方法和用途 |
JP2013503138A (ja) * | 2009-08-26 | 2013-01-31 | エムビー ミルメド エービー | 電磁放射酵母を含む神経変性疾患または障害の処置のための組成物、方法および使用 |
US9320768B2 (en) | 2009-08-26 | 2016-04-26 | Milmed Ab | Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002062984A1 (fr) | Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications | |
Karamać et al. | Use of different proteases to obtain flaxseed protein hydrolysates with antioxidant activity | |
WO2002062981A1 (fr) | Immunoregulateur humain de levure et son procede de preparation | |
WO2002062983A1 (fr) | Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications | |
WO2002062985A1 (fr) | Levure faisant preuve d'un activite immunoregulatrice cellulaire nk, son procede de preparation et ses applications | |
Achilladelis et al. | The dynamics of technological innovation: the case of the pharmaceutical industry | |
Guan et al. | In vitro efficacy of Myxococcus fulvus ANSM068 to biotransform aflatoxin B1 | |
WO2002062982A1 (fr) | Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications | |
EP4248751A3 (fr) | Modalites ameliorees du traitement des maladies degeneratives de la retine | |
WO1998019167A3 (fr) | Gene de classe i du complexe majeur d'histocompatibilite humain a stress cellulaire regule | |
WO2005046570A3 (fr) | Materiaux de cellule souche humaine et procedes associes | |
Li et al. | Investigation of Chlorella pyrenoidosa protein as a source of novel angiotensin I-converting enzyme (ACE) and dipeptidyl peptidase-IV (DPP-IV) inhibitory peptides | |
Zieliński et al. | ACE inhibitory properties and phenolics profile of fermented flours and of baked and digested biscuits from buckwheat | |
Sagu et al. | Comprehensive characterization and relative quantification of α-amylase/trypsin inhibitors from wheat cultivars by targeted HPLC-MS/MS | |
Mazloomi et al. | Impact of simulated gastrointestinal digestion on the biological activity of an alcalase hydrolysate of orange seed (Siavaraze, Citrus sinensis) by-products | |
Laurent-Babot et al. | Should research on the nutritional potential and health benefits of fermented cereals focus more on the general health status of populations in developing countries? | |
Galli et al. | Antioxidant properties of sourdoughs made with whole grain flours of hull-less barley or conventional and pigmented wheat and by selected lactobacilli strains | |
Ulvestad | Psychoneuroimmunology: the experiential dimension | |
WO2001053340A3 (fr) | Modele murin transgenique de maladies neurodegeneratives humaines | |
Kęska et al. | Stability of antiradical activity of protein extracts and hydrolysates from dry-cured pork loins with probiotic strains of LAB | |
Luti et al. | Bioactive properties of breads made with sourdough of Hull-less barley or conventional and pigmented wheat flours | |
Karthivashan et al. | Comparative studies on behavioral, cognitive and biomolecular profiling of ICR, C57BL/6 and its sub-strains suitable for scopolamine-induced amnesic models | |
Liu et al. | Efficient hydrolysis of gluten-derived celiac disease-triggering immunogenic peptides by a bacterial serine protease from Burkholderia gladioli | |
WO2004018633A3 (fr) | Acides nucleiques et proteines abca13 : utilisations | |
WO2006025995A3 (fr) | Compositions et methodes faisant intervenir des mutants md-2 et des proteines chimeres |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |